Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2026-01-24 @ 10:50 PM
Study NCT ID:
NCT00022451
Status:
COMPLETED
Last Update Posted:
2012-03-15
First Post:
2001-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tipifarnib in Treating Young Patients With Refractory Leukemia
Sponsor:
National Institutes of Health Clinical Center (CC)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Leukemia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent childhood acute lymphoblastic leukemia | View |
| None | recurrent childhood acute myeloid leukemia | View |
| None | relapsing chronic myelogenous leukemia | View |
| None | blastic phase chronic myelogenous leukemia | View |
| None | chronic myelogenous leukemia, BCR-ABL1 positive | View |
| None | childhood acute promyelocytic leukemia (M3) | View |
| None | acute undifferentiated leukemia | View |
| None | juvenile myelomonocytic leukemia | View |
| None | childhood chronic myelogenous leukemia | View |